DataMEDS AI Statistics
Total Valuation
DataMEDS AI has a market cap or net worth of $6.40 million. The enterprise value is $36.57 million.
| Market Cap | 6.40M |
| Enterprise Value | 36.57M |
Important Dates
The last earnings date was Monday, August 17, 2026, before market open.
| Earnings Date | Aug 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DataMEDS AI has 3.06 million shares outstanding. The number of shares has increased by 93.15% in one year.
| Current Share Class | 3.06M |
| Shares Outstanding | 3.06M |
| Shares Change (YoY) | +93.15% |
| Shares Change (QoQ) | +23.05% |
| Owned by Insiders (%) | 45.00% |
| Owned by Institutions (%) | 3.36% |
| Float | 1.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.33 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.14
| Current Ratio | 0.14 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.72 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -82.93% |
| Return on Invested Capital (ROIC) | -186.56% |
| Return on Capital Employed (ROCE) | 867.20% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.18 |
| Inventory Turnover | 2.90 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.27% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -97.27% |
| 50-Day Moving Average | 2.07 |
| 200-Day Moving Average | 9.42 |
| Relative Strength Index (RSI) | 64.16 |
| Average Volume (20 Days) | 2,026,045 |
Short Selling Information
The latest short interest is 173,986, so 5.68% of the outstanding shares have been sold short.
| Short Interest | 173,986 |
| Short Previous Month | 164,850 |
| Short % of Shares Out | 5.68% |
| Short % of Float | 11.72% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, DataMEDS AI had revenue of $8.02 million and -$88.28 million in losses. Loss per share was -$43.73.
| Revenue | 8.02M |
| Gross Profit | -7.27M |
| Operating Income | -57.71M |
| Pretax Income | -88.28M |
| Net Income | -88.28M |
| EBITDA | -55.39M |
| EBIT | -57.71M |
| Loss Per Share | -$43.73 |
Balance Sheet
The company has $2.46 million in cash and $32.62 million in debt, with a net cash position of -$30.17 million or -$9.85 per share.
| Cash & Cash Equivalents | 2.46M |
| Total Debt | 32.62M |
| Net Cash | -30.17M |
| Net Cash Per Share | -$9.85 |
| Equity (Book Value) | -19.50M |
| Book Value Per Share | -6.88 |
| Working Capital | -33.78M |
Cash Flow
| Operating Cash Flow | -13.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.32M |
| Net Borrowing | 8.35M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -90.64% |
| Operating Margin | -719.27% |
| Pretax Margin | -1,100.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DataMEDS AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -93.15% |
| Shareholder Yield | -93.15% |
| Earnings Yield | -3,313.86% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 18.40% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 26, 2026. It was a reverse split with a ratio of 1:50.
| Last Split Date | May 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
DataMEDS AI has an Altman Z-Score of -12.18 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.18 |
| Piotroski F-Score | 1 |